POLE and neoplasm: Indeed, the Refining Adjuvant treatment In EC Based On molecular features (RAINBO) phase II trial is randomising patients with POLE mutated tumours to de-escalation of adjuvant treatment after surgery even for stage III tumours (NCT05255653) [11].